Date:27-Apr-2024  Time: 12:00 PM
 
 
        
Natco Pharma Ltd
Quarters:       (Rs. In Crores)
ParticularsDec 2023Sep 2023Jun 2023Mar 2023
Type3Qtr2Qtr1Qtr4Qtr
Net Sales625.30930.501048.30781.20
Other Income29.5024.7014.6017.50
Total Income654.80955.201062.90798.70
Total Expenditure 387.00488.20544.60453.50
Operating Profit267.80467.00518.30345.20
Interest3.803.003.201.20
Gross Profit264.00464.00515.10344.00
Depreciation40.4040.0039.9037.60
Tax42.1075.3083.8049.90
Deferred Tax-10.50-11.50-13.902.40
Reported Profit After Tax192.00360.20405.30254.10
Source:Capital Market
 
Useful linksNSEIBSEI SEBIINSDLI NCDEXI CDSLIRBI      Careers | Feedback | Sitemap | Disclaimer | Privacy Policy | Grievances
Sebi Reg No: NSE INB231168734(CM) INF231168734(F&O) Sebi Reg No: BSE INB011168730 INF011168730   NCDEX: Membership Code: 00774
MCX: Membership Code: 31560  Mutual Funds: ARN0843.
FMC Unique Membership Code: MCX/TCM/CORP/1106
2006-07 © Senator Securities Pvt. Ltd. All rights reserved
FMC Unique Membership Code: NCDEX/TCM/CORP/0760
Design, developed & maintained by C-MOTS Infotech(ISO 9001:2000 certified)
Content powered by capitalmarket.com